韩国首次开展了空间生物实验,在微重力中测试干细胞生长的心脏组织。 South Korea launched its first space-based biological experiment, testing stem cell-grown heart tissue in microgravity.

韩国在Hallym大学的Chan Heum Park教授的团队研制的BioCabinet号上用Nuri火箭发射了首次空间生物实验。 South Korea launched its first space-based biological experiment with the BioCabinet, developed by Professor Chan Heum Park’s team at Hallym University, aboard the Nuri rocket. 为期60天的任务可扩展至一年,测试微重力干细胞的人造心脏组织生长,评估心脏收缩和血管形成。 The 60-day mission, extendable to a year, tests artificial heart tissue growth from stem cells in microgravity, assessing cardiac contractions and blood vessel formation. 它标志着该国首次收集空间生物组织数据,利用微重力改善3D组织发展和药物结晶。 It marks the nation’s first collection of biological tissue data in space, leveraging microgravity for improved 3D tissue development and drug crystallization. 该小组正在进一步推进一些项目,如用于癌症药物筛查的BioRexs项目和用于空间制造肝脏组织的BioLiv项目,将韩国定位为空间生物工程中不断崛起的参与者。 The team is advancing further with projects like BioRexs for cancer drug screening and BioLiv for space-fabricated liver tissue, positioning South Korea as a rising player in space bioengineering.